Patents

US 10016458 B2: p53 silenced endothelial progenitor cells for diabetes

Granted
2018-07-10
Filed
2013-03-11 application 13794567
Type
Utility · 16 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The invention provides, inter alia, methods for treating vascular deficiencies, including those in diabetic subjects, by transplanting endothelial progenitor cells with transiently reduced p53 expression.

Source: PVGPATDIS, file of 2026-04-10 (ipg180710.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Baystate Health, Inc. 4 patentsUS company or organizationSpringfield, MABAYSTATE HEALTH INC Nonprofit EXACT high confidence: identical full name and statePVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Sabyasachi SenLongmeadow, MA2PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K35/14PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2013-04-26Assignment
Assignment of assignor's interest
SEN, SABYASACHI signed 2013-04-02BAYSTATE HEALTH, INC. SPRINGFIELD, MA30296/237ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.